Cover Image

Polymorphisms in CXCR3 ligands predict early CXCL9 recovery and severe chronic GVHD

Chronic graft-versus-host disease (cGVHD) is a major cause of mortality and morbidity after allogeneic stem cell transplantation (alloSCT). The individual risk of severe cGVHD remains difficult to predict and may involve CXCR3 ligands. This study investigated the role of single-nucleotide polymorphi...

Full description

Saved in:
Bibliographic Details
Main Authors: Dai, Hao (Author) , Rachakonda, P. Sivaramakrishna (Author) , Penack, Olaf (Author) , Blau, Igor W. (Author) , Blau, Olga (Author) , Radujković, Aleksandar (Author) , Müller-Tidow, Carsten (Author) , Dreger, Peter (Author) , Kumar, Rajiv (Author) , Luft, Thomas (Author)
Format: Article (Journal)
Language:English
Published: 27 February 2021
In: Blood cancer journal
Year: 2021, Volume: 11, Issue: 2, Pages: 1-12
ISSN:2044-5385
DOI:10.1038/s41408-021-00434-2
Online Access:Verlag, kostenfrei, Volltext: https://doi.org/10.1038/s41408-021-00434-2
Verlag, kostenfrei, Volltext: https://www.nature.com/articles/s41408-021-00434-2
Get full text
Author Notes:Hao Dai, Sivaramakrishna P. Rachakonda, Olaf Penack, Igor W. Blau, Olga Blau, Aleksandar Radujkovic, Carsten Müller-Tidow, Peter Dreger, Rajiv Kumar and Thomas Luft

MARC

LEADER 00000caa a2200000 c 4500
001 1753267269
003 DE-627
005 20230426165447.0
007 cr uuu---uuuuu
008 210407s2021 xx |||||o 00| ||eng c
024 7 |a 10.1038/s41408-021-00434-2  |2 doi 
035 |a (DE-627)1753267269 
035 |a (DE-599)KXP1753267269 
035 |a (OCoLC)1341403682 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Dai, Hao  |d 1989-  |e VerfasserIn  |0 (DE-588)1194475671  |0 (DE-627)1676494774  |4 aut 
245 1 0 |a Polymorphisms in CXCR3 ligands predict early CXCL9 recovery and severe chronic GVHD  |c Hao Dai, Sivaramakrishna P. Rachakonda, Olaf Penack, Igor W. Blau, Olga Blau, Aleksandar Radujkovic, Carsten Müller-Tidow, Peter Dreger, Rajiv Kumar and Thomas Luft 
264 1 |c 27 February 2021 
300 |a 12 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am 07.04.2021 
520 |a Chronic graft-versus-host disease (cGVHD) is a major cause of mortality and morbidity after allogeneic stem cell transplantation (alloSCT). The individual risk of severe cGVHD remains difficult to predict and may involve CXCR3 ligands. This study investigated the role of single-nucleotide polymorphisms (SNPs) of CXCL4, CXCL9, CXCL10, and CXCL11, and their day +28 serum levels, in cGVHD pathogenesis. Eighteen CXCR3 and CXCL4, CXCL9-11 SNPs as well as peri-transplant CXCL9-11 serum levels were analyzed in 688 patients without (training cohort; n = 287) or with statin-based endothelial protection cohort (n = 401). Clinical outcomes were correlated to serum levels and SNP status. Significant polymorphisms were further analyzed by luciferase reporter assays. Findings were validated in an independent cohort (n = 202). A combined genetic risk comprising four CXCR3 ligand SNPs was significantly associated with increased risk of severe cGVHD in both training cohort (hazard ratio (HR) 2.48, 95% confidence interval (CI) 1.33-4.64, P = 0.004) and validation cohort (HR 2.95, 95% CI 1.56-5.58, P = 0.001). In reporter assays, significantly reduced suppressive effects of calcineurin inhibitors in constructs with variant alleles of rs884304 (P < 0.001) and rs884004 (P < 0.001) were observed. CXCL9 serum levels at day +28 after alloSCT correlated with both genetic risk and risk of severe cGVHD (HR 1.38, 95% CI 1.10-1.73, P = 0.006). This study identifies patients with high genetic risk to develop severe cGVHD. 
700 1 |a Rachakonda, P. Sivaramakrishna  |d 1969-  |e VerfasserIn  |0 (DE-588)130641847  |0 (DE-627)504917307  |0 (DE-576)298317222  |4 aut 
700 1 |a Penack, Olaf  |e VerfasserIn  |4 aut 
700 1 |a Blau, Igor W.  |e VerfasserIn  |4 aut 
700 1 |a Blau, Olga  |e VerfasserIn  |4 aut 
700 1 |a Radujković, Aleksandar  |d 1980-  |e VerfasserIn  |0 (DE-588)132951320  |0 (DE-627)529183536  |0 (DE-576)299523721  |4 aut 
700 1 |a Müller-Tidow, Carsten  |d 1968-  |e VerfasserIn  |0 (DE-588)1015101798  |0 (DE-627)705330230  |0 (DE-576)351197893  |4 aut 
700 1 |a Dreger, Peter  |e VerfasserIn  |0 (DE-588)1028891881  |0 (DE-627)732699894  |0 (DE-576)376320966  |4 aut 
700 1 |a Kumar, Rajiv  |d 1955-  |e VerfasserIn  |0 (DE-588)1164253425  |0 (DE-627)1028811942  |0 (DE-576)508469805  |4 aut 
700 1 |a Luft, Thomas  |e VerfasserIn  |0 (DE-588)1078976309  |0 (DE-627)839996969  |0 (DE-576)452120659  |4 aut 
773 0 8 |i Enthalten in  |t Blood cancer journal  |d [London] : Springer Nature, 2011  |g 11(2021), 2, Artikel-ID 42, Seite 1-12  |h Online-Ressource  |w (DE-627)655134174  |w (DE-600)2600560-8  |w (DE-576)339571802  |x 2044-5385  |7 nnas  |a Polymorphisms in CXCR3 ligands predict early CXCL9 recovery and severe chronic GVHD 
773 1 8 |g volume:11  |g year:2021  |g number:2  |g elocationid:42  |g pages:1-12  |g extent:12  |a Polymorphisms in CXCR3 ligands predict early CXCL9 recovery and severe chronic GVHD 
856 4 0 |u https://doi.org/10.1038/s41408-021-00434-2  |x Verlag  |x Resolving-System  |z kostenfrei  |3 Volltext 
856 4 0 |u https://www.nature.com/articles/s41408-021-00434-2  |x Verlag  |z kostenfrei  |3 Volltext 
951 |a AR 
992 |a 20210407 
993 |a Article 
994 |a 2021 
998 |g 1078976309  |a Luft, Thomas  |m 1078976309:Luft, Thomas  |d 910000  |d 910100  |d 50000  |e 910000PL1078976309  |e 910100PL1078976309  |e 50000PL1078976309  |k 0/910000/  |k 1/910000/910100/  |k 0/50000/  |p 10  |y j 
998 |g 1164253425  |a Kumar, Rajiv  |m 1164253425:Kumar, Rajiv  |d 50000  |e 50000PK1164253425  |k 0/50000/  |p 9 
998 |g 1028891881  |a Dreger, Peter  |m 1028891881:Dreger, Peter  |d 910000  |d 910100  |e 910000PD1028891881  |e 910100PD1028891881  |k 0/910000/  |k 1/910000/910100/  |p 8 
998 |g 1015101798  |a Müller-Tidow, Carsten  |m 1015101798:Müller-Tidow, Carsten  |d 910000  |d 910100  |e 910000PM1015101798  |e 910100PM1015101798  |k 0/910000/  |k 1/910000/910100/  |p 7 
998 |g 132951320  |a Radujković, Aleksandar  |m 132951320:Radujković, Aleksandar  |d 910000  |d 910100  |d 50000  |e 910000PR132951320  |e 910100PR132951320  |e 50000PR132951320  |k 0/910000/  |k 1/910000/910100/  |k 0/50000/  |p 6 
998 |g 130641847  |a Rachakonda, P. Sivaramakrishna  |m 130641847:Rachakonda, P. Sivaramakrishna  |p 2 
998 |g 1194475671  |a Dai, Hao  |m 1194475671:Dai, Hao  |p 1  |x j 
999 |a KXP-PPN1753267269  |e 3903096644 
BIB |a Y 
SER |a journal 
JSO |a {"id":{"eki":["1753267269"],"doi":["10.1038/s41408-021-00434-2"]},"name":{"displayForm":["Hao Dai, Sivaramakrishna P. Rachakonda, Olaf Penack, Igor W. Blau, Olga Blau, Aleksandar Radujkovic, Carsten Müller-Tidow, Peter Dreger, Rajiv Kumar and Thomas Luft"]},"recId":"1753267269","physDesc":[{"extent":"12 S."}],"title":[{"title_sort":"Polymorphisms in CXCR3 ligands predict early CXCL9 recovery and severe chronic GVHD","title":"Polymorphisms in CXCR3 ligands predict early CXCL9 recovery and severe chronic GVHD"}],"language":["eng"],"type":{"media":"Online-Ressource","bibl":"article-journal"},"note":["Gesehen am 07.04.2021"],"origin":[{"dateIssuedDisp":"27 February 2021","dateIssuedKey":"2021"}],"person":[{"family":"Dai","given":"Hao","role":"aut","display":"Dai, Hao"},{"display":"Rachakonda, P. Sivaramakrishna","given":"P. Sivaramakrishna","role":"aut","family":"Rachakonda"},{"family":"Penack","role":"aut","given":"Olaf","display":"Penack, Olaf"},{"family":"Blau","role":"aut","given":"Igor W.","display":"Blau, Igor W."},{"family":"Blau","given":"Olga","role":"aut","display":"Blau, Olga"},{"given":"Aleksandar","role":"aut","family":"Radujković","display":"Radujković, Aleksandar"},{"display":"Müller-Tidow, Carsten","family":"Müller-Tidow","role":"aut","given":"Carsten"},{"family":"Dreger","role":"aut","given":"Peter","display":"Dreger, Peter"},{"display":"Kumar, Rajiv","role":"aut","given":"Rajiv","family":"Kumar"},{"given":"Thomas","role":"aut","family":"Luft","display":"Luft, Thomas"}],"relHost":[{"disp":"Polymorphisms in CXCR3 ligands predict early CXCL9 recovery and severe chronic GVHDBlood cancer journal","recId":"655134174","physDesc":[{"extent":"Online-Ressource"}],"id":{"zdb":["2600560-8"],"eki":["655134174"],"issn":["2044-5385"]},"title":[{"title_sort":"Blood cancer journal","title":"Blood cancer journal"}],"part":{"issue":"2","text":"11(2021), 2, Artikel-ID 42, Seite 1-12","extent":"12","pages":"1-12","volume":"11","year":"2021"},"type":{"bibl":"periodical","media":"Online-Ressource"},"language":["eng"],"note":["Gesehen am 17.07.24"],"origin":[{"publisher":"Springer Nature ; Nature Publ. Group","dateIssuedDisp":"2017-","dateIssuedKey":"2017","publisherPlace":"[London] ; London [u.a.]"}],"pubHistory":["1.2011-"]}]} 
SRT |a DAIHAORACHPOLYMORPHI2720 

Similar Items